secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0001847903-24-000041
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa files 8-K referencing SerpinPC clinical update but no data in exhibit
------------------------------------------------------------------------------

- Exhibit 99.1 only contains a title slide and standard disclaimers; no numerical results provided.
- Presentation is posted on company website but not fully reproduced in the filing.
- SerpinPC is an investigational serpin for haemophilia A/B with or without inhibitors.
- No financial or guidance changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790324000041/0001847903-24-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790324000041/cnta-20240209.htm
  HTML page:      https://secwatch.observer/filing/0001847903-24-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer